In recent years, the receptor tyrosine kinase HER3 (also known as ErbB3) has emerged from relative obscurity to occupy a...
In the relentless quest to better understand and treat cancer, the concept of surrogate end points has surfaced as a...
In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a...
In recent years, the landscape of multiple myeloma (MM) diagnosis and treatment has undergone a profound transformation, largely driven by...
The landscape of cancer diagnostics has witnessed transformative advancements, particularly in the realm of human epidermal growth factor receptor 2...
In an era where early cancer detection defines the edge of clinical success, a groundbreaking study published in BMC Cancer...
Pancreatic ductal adenocarcinoma (PDAC) remains one of the most formidable challenges in oncology, persistently defying decades of therapeutic innovation and...
The landscape of non-small cell lung cancer (NSCLC) treatment has undergone a radical transformation in recent years, driven by advances...
In a significant advancement for the treatment of advanced cutaneous squamous cell carcinoma (cSCC), a phase II clinical trial spearheaded...
The landscape of anal squamous cell carcinoma (ASCC), a rare yet increasingly prevalent malignancy, is undergoing a profound transformation fueled...
The relentless challenge posed by glioblastoma multiforme (GBM), the most aggressive and lethal primary brain tumor, continues to galvanize oncological...
Immune checkpoint inhibitors (ICIs) have rapidly transformed the landscape of oncology by harnessing the body’s immune system to combat malignancies....
In a groundbreaking study published in BMC Cancer, researchers unveil the pivotal role of a circular RNA, circSLC22A3, in suppressing...
As of January 1, 2025, it is estimated that nearly 18.6 million individuals in the United States are living with...
In a groundbreaking advancement that could redefine the prognosis for a challenging subset of metastatic colorectal cancer (mCRC) patients, the...
Researchers from Mass General Brigham are poised to unveil groundbreaking advancements in cancer therapy and supportive care at the 2025...
In a groundbreaking fusion of computational engineering and immunotherapy, Dr. Natasa Miskov-Zivanov, an assistant professor of electrical and computer engineering...
A groundbreaking advancement in cancer therapeutics is emerging from a recent international clinical trial investigating the novel targeted therapy, DB-1310....
Central to this breakthrough is the use of a thermo-ionically reversible hydrogel system, enabling the encapsulation of human salivary gland...
In a groundbreaking study that redefines our understanding of chromosome architecture, researchers from the Institute of Science Tokyo have unveiled...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.